Browsing by Author Lam, AM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
Inhibition of hepatitis B surface antigen by RNA interference therapeutic AB-729 in chronic hepatitis B patients correlates with suppression of all HBsAg isoforms and HBV RNA
Proceeding/Conference:Journal of Hepatology
Thi, EPYuen, RMFGane, ESevinsky, HSims, KAnderson, MLam, AMSofia, MJCloherty, GPicchio, G
2021
 
Inhibition of hepatitis B surface antigen by RNA interference therapeutic AB-729 is associated with increased cytokine signatures in HBV DNA+ chronic hepatitis B patients. Poster Presentation (SAT396)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Ganchua, SParatala, BIott, CYuen, RMFGane, EJEley, TSims, KGray, KAntoniello, DLam, AMSofia, MJPicchio, GThi, EP
2022
 
Inhibition of hepatitis B surface antigen in chronic hepatitis B subjects by RNA interference therapeutic AB-729 is accompanied by upregulation of HBV-specific T cell activation markers
Proceeding/Conference:Journal of Hepatology
Paratala, BPark, J-JGanchua, SCGane, EYuen, RMFLee, ACHMoore, CLam, AMSevinsky, HSims, KAntoniello, DSofia, MJPicchio, GThi, EP
2021
 
Reduction of hepatitis B surface antigen mediated by RNA interference therapeutic AB-729 in chronic hepatitis B patients is associated with T cell activation and a decline in exhausted CD8 T cells. Poster Presentation (SAT397)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Ganchua, SCParatala, BIott, CGane, EJYuen, RMFEley, TSims, KGray, KAntoniello, DLam, AMSofia, MJPicchio, GThi, EP
2022
Showing results 1 to 4 of 4